Abstract
Palmoplantar pustulosis is a difficult-to-treat, immune-mediated skin disease that presents as sterile pustules on the palms and soles. While thought to be related to psoriasis vulgaris, precise biologics that target the same cytokines as psoriasis vulgaris have led to inadequate and difficult treatment. Topical corticosteroids have a broader anti-inflammatory profile compared with biologics but are limited by adverse events making chronic treatment unsuitable. We report the case of an 82-year-old patient who was successfully treated with topical roflumilast 0.3% once daily for the treatment of palmoplantar pustulosis that was refractory to topical corticosteroid use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
